The following are two large companies, MDH and Patanjali, and what happened to them.
During the first hearing on November 21, 2023, Justice Amanullah orally warned Patanjali against claiming their products could completely "cure" diseases. The court threatened to impose a cost of Rs 1 crore on every product for which such a claim was made. Despite this warning, Patanjali continued to organize press conferences and give misleading advertisements about their products, claiming to cure ailments caused by sugar, obesity, blood pressure, and other diseases.
The Supreme Court issued a contempt notice to Patanjali Ayurveda and its managing director, Acharya Balkrishna, for disregarding its order against misleading advertisements. The court also prohibited Patanjali from promoting its medical products until further notice. The Supreme Court barred Patanjali Ayurved Limited from advertising products intended for medical ailments.
MDH (Mahashian Di Hatti) and Everest are popular spice brands recently scrutinised by food authorities in India, Singapore, and Hong Kong.
The Singapore Food Agency ordered a recall of Everest's Fish Curry Masala due to ethylene oxide at levels exceeding permissible limits. Similarly, Hong Kong advised people to stop consuming several MDH products.
The Supreme Court's actions aim to curb misleading advertisements and ensure that companies adhere to ethical practices when promoting their products. These cases serve as a reminder that claims made in advertisements must be backed by scientific evidence and comply with relevant laws and regulations.